Ticovac™ (tick-borne encephalitis vaccine) – New vaccine approval
August 13, 2021 - Pfizer announced the FDA approval of Ticovac (tick-borne encephalitis vaccine), for active immunization to prevent tick-borne encephalitis (TBE). Ticovac is approved for use in individuals 1 year of age and older.
Download PDF
